Relating to manufacturers and distributors of 340B drugs

Where it is now

Done: IntroducedJanuary 13, 2026
Done: SubcommitteeJanuary 14, 2026
Stopped: House committeeDied when the General Assembly ended
Next: Passes the House
Next: Senate committeeFunnel: by March 20, 2026
Next: Passes the Senate
Next: To the Governor
Next: Signed into law

Died when the session ended The 2026 session adjourned on May 3, 2026, the General Assembly’s last regular session. Bills that didn’t pass both chambers died. What’s a funnel?

What’s in it

AI summary Drug companies and distributors would be stopped from blocking or interfering with how certain healthcare providers get discounted 340B drugs. This rule also prevents them from stopping these drugs from being sent to contract pharmacies. These restrictions apply unless the U.S. Department of Health and Human Services says otherwise.¹

Read the official explanation

This bill relates to manufacturers and distributors of 340B drugs. “340B drug”, “manufacturer”, and “distributor” are defined in the bill. The bill prohibits a manufacturer or distributor from, directly or indirectly, denying, restricting, or interfering with the acquisition of a 340B drug by a covered entity, or the delivery of a 340B drug to a contract pharmacy, unless otherwise prohibited by the United States department of health and human services.

Full bill text²

House subcommittee

Named January 14, 2026. On January 21, 2026 it recommended passage.

Three legislators hear a bill first and recommend what the committee should do; it’s the best time to weigh in. How to take part

Iowa Code it changes

Amends§510D.1 §510D.2

How the Code works³

Lobbying

8 for · 10 against · 10 undecided · Who →

Family tree

91st General Assembly

HF 2009Cleared committeeHouse companion SF 2312Cleared committeeSenate companion

Similar bills

HF 590 Relating to manufacturers and distributors of 340B drugs
91st General Assembly · In committee
Nearly identical

Matched by wording or an identical title.